Suchergebnisse - "Antony Justin"

PubPharm (56)

1

Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9

enthalten in: Biotechnology journal | 2024

von Antony, J. | Herranz, A. | Mohammadian Gol, T. | +9

2

Quinone scaffolds as potential therapeutic anticancer agents: Chemistry, mechanism of Actions, Structure-Activity relationships and future perspectives

in: Results in Chemistry | 2024

von Syed Faizan | Maged Mohammed Abdo Mohsen | Chinmya Amarakanth | +4

3

Accelerated generation of gene‐engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9

enthalten in: Biotechnology Journal | 2024

von Antony, J. | Herranz, A. | Mohammadian Gol, T. | +9

4

Local application of engineered insulin-like growth factor I mRNA demonstrates regenerative therapeutic potential in vivo

enthalten in: Molecular therapy. Nucleic acids | 2023

von Antony, J. | Birrer, P. | Bohnert, C. | +11

5

CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells

enthalten in: International journal of molecular sciences | 2023

von Mohammadian Gol, T. | Kim, M. | Sinn, R. | +7

6

Generation of a heterozygous and a homozygous CSF1R knockout line from iPSC using CRISPR/Cas9

enthalten in: Stem cell research | 2023

von Schmitz, A. | Korneck, M. | Raju, J. | +7

7

A combination of Metformin and Epigallocatechin Gallate Potentiates Glioma Chemotherapyin vivo

enthalten in: bioRxiv.org | 2023

von Kuduvalli, S. | Precilla, S. | Vaithy, A. | +10

8

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

enthalten in: Frontiers in pharmacology | 2023

von Kuduvalli, S. | Daisy, P. | Vaithy, A. | +10

ErratumIn: Front Pharmacol. 2024 Jan 09;14:1322332. - PMID 38264527

9

Corrigendum : A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

enthalten in: Frontiers in pharmacology | 2023

von Kuduvalli, S. | Daisy, P. | Vaithy, A. | +10

ErratumFor: Front Pharmacol. 2023 Mar 21;14:1096614. - PMID 37025487

10

Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing

enthalten in: Genes | 2022

von Hou, Y. | Ureña-Bailén, G. | Mohammadian Gol, T. | +8

1
2
3
4
5
6
Nächster »
[6]